Cost-effectiveness and impact of five different point of care strategies to preserve last line treatment for gonorrhoea
Cost-effectiveness of antimicrobial resistance point-of-care testing for optimising gonorrhoea treatment
Modelling how point-of-care tests can enable personalised treatment for resistant gonorrhoea infections
Managing Mycoplasma genitalium as an STI
